3/5/2019NMPA Switches Three OTC Medicines to Rx Status

3/5/2019Novartis Reports Positive Data from Chinese Trial of Cosentyx for Psor...

3/4/2019TLC and 3SBio Form Exclusive Partnership to Commercialize Two NanoX Pr...

3/4/2019NHSA Commissioner Reveal Plan to Revise NRDL in 2019 at the Two Sessio...

3/1/2019Recent Executive Moves

3/1/2019IQVIA/McKinsey: Generics Continue to Dominate Chinese Pharma Market

3/1/2019IQVIA Publishes Report on Orphan Drug Access in China as the Country B...

3/1/2019CDE Solicits Comments on eCTD Technical and Validation Guidelines

3/1/2019I-Mab Biopharma and BCT to Collaborate on Arginine Depletion Therapy a...

3/1/2019Eli Lilly's Diabetes Drug Once-Weekly Trulicity (dulaglutide) Approved...

3/1/2019Fosun to Expand Gland Pharma Operations in India

3/1/2019Pharma China Annual Forum 2019 (April 9, Shanghai)

3/1/2019Abpro Enters $4B Bispecifics Deal with Chia Tai Tianqing Pharma

3/1/2019Novo Nordisk Becomes First to Sign Bilateral APA with China

3/1/2019Financial-related Company News in Brief 02/2019

3/1/2019China Sends Mixed Signals for Healthcare as Outlook Shift from Cautiou...

2/28/2019Biogen Further Expands Presence in China with Approval of SPINRAZA (nu...

2/28/2019NHSA Holds Hearing of Pharmaceutical Industry Representatives

2/27/2019NHC Publishes China's First Clinical Guidelines for Rare Diseases

2/27/20192019 AmCham China Business Climate Survey: Growth Continues Amid Heigh...

2/27/2019NHSA to Step Up Fraud Crackdown with New Document on BMI Fund Regulati...

2/27/2019NHC Solicits Comments on the Provisions for Clinical Application of Ne...

2/27/2019NMPA, KFDA Sign MOU for Drug, Medical and Cosmetic Regulation

2/27/2019New IFPMA Code of Practice Tightens Restrictions on Gifts (with Case o...

2/26/2019CDE Publicizes 11 More Drug Applications To Be Granted Priority Review...

2/26/2019China Launches Research on Blood Control Target among Diabetics Patien...

2/26/2019Chinese Biotech Feels Chill in Harsh Winter for Venture Capital

2/26/2019Temasek Leads $85M Series B Round for China-based Gracell Biotech

2/26/2019China Approves Rituxan Copy as the First Biosimilar in China

2/25/2019NMPA Holds National Drug ADR Conference, Outlining Major Tasks in 2019

Page:320/803 Total number of articles:24087: [First][<<] [318] [319] [320] [321] [322] [>>] [End]